Pune, India -- (SBWire) -- 04/13/2019 --Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Key players in details:
Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals, McNeil Consumer Healthcare, Sebela Pharmaceuticals, Astellas Pharmaceuticals, IM HealthScience and Others.
The worldwide market for Irritable Bowel Syndrome (IBS) is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 6530 million US$ in 2024, from 2640 million US$ in 2019, according to recent research.
For More information Register free sample copy of this report here:
https://www.verifiedmarketreports.com/download-sample/?rid=39396&mode=BRG10
Market is segmented on the basis Type, Application and Region:
Global Irritable Bowel Syndrome (IBS) Market segment by type: IBS-D Drug, IBS-C Drug, Other.
Global Irritable Bowel Syndrome (IBS) Market Segment by Applications: Women, Men.
Scope of the Report:
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
Irritable Bowel Syndrome (IBS) Market report comprises key factor which can be useful for any new player in the industry. It is possible due to comparative analysis and overview that is provided in the report. By focusing on all the details in the report, it is more than enough for any newcomers entering the industry so that they can get a better knowledge and study the market before making any strategic decision.
To know more about this report:
https://www.verifiedmarketreports.com/product/global-irritable-bowel-syndrome-ibs-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024/?mode=BRG10
Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of product in these regions, from 2017 to 2024 (forecast), covering United States, North America (Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa), RoW (Rest of World).
There are 15 Chapters to deeply display the global Irritable Bowel Syndrome (IBS) market:
Chapter 1, to describe Irritable Bowel Syndrome (IBS) Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Irritable Bowel Syndrome (IBS), with sales, revenue, and price of Irritable Bowel Syndrome (IBS) Market, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Irritable Bowel Syndrome (IBS), for each region, from 2013 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the Irritable Bowel Syndrome (IBS) Market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2019;
Chapter 12, Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) Market sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Avail Discount for this report at:
https://www.verifiedmarketreports.com/ask-for-discount/?rid=39396&mode=BRG10
About Verified Market Reports
Verified Market Reports is part of the Verified Market Research which offers premium reports from over hundreds of top publishers worldwide. It has the most widespread collection of market research reports, analysis & forecast data for businesses and governments. We update and improve our repository routinely to deliver instant online access to the world's most comprehensive and current database of expert insights.
Contact Us:
sales@verifiedmarketreports.com | +1 (704) 266-3234
Irritable Bowel Syndrome (IBS) Market Clinical Aspects, Review, Survey Reports 2019
Verifiedmarketreports.com has announced the addition of the “Global Irritable Bowel Syndrome (IBS) Market Research Report” The report focuses on global major leading players with information such as company profiles, product picture and specification.